.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Surgeons continuously seek ways to optimize care for patients with Crohn's disease. Recent research suggests that an end-to-side ileocolonic anastomosis significantly improves outcomes after ileocecectomy. Although various configurations like the Kono-S or side-to-side are common, this specific method offers distinct advantages. Consequently, understanding these clinical benefits helps surgeons make more informed decisions during reconstructive procedures.
A retrospective study at the University of Chicago Medical Center evaluated 239 patients who underwent surgery between 2018 and 2022. Researchers compared multiple configurations, including end-to-end and side-to-side techniques. Notably, the end-to-side approach demonstrated superior results regarding efficiency and safety. For instance, patients receiving this configuration experienced lower blood loss and shorter operative times.
Furthermore, the long-term data revealed a compelling trend in disease management. On multivariable analysis, elective surgery and the end-to-side configuration correlated with lower rates of Crohn's disease recurrence. Moreover, with an average follow-up of 32 months, this technique appears to be a technically simple yet highly effective method. Therefore, clinicians should consider this approach as a viable standard for ileocolonic reconstruction in Crohn's patients.
The choice of anastomosis remains a critical factor in preventing postoperative complications. Additionally, the study emphasizes that technically easy methods often yield the best surgical outcomes. Because the end-to-side configuration reduces time in the operating room, it may lower the overall risk of surgical site infections. Thus, adopting this configuration could enhance recovery protocols in high-volume inflammatory bowel disease centers.
No, surgeons consider it a technically easy and safe reconstruction method. It often requires less operative time compared to more complex handsewn techniques like the Kono-S.
Yes, clinical data indicate that the end-to-side configuration is associated with significantly lower recurrence rates over a 32-month follow-up period compared to other configurations.
Beyond lower recurrence, patients who received an end-to-side anastomosis also experienced lower blood loss and shorter durations in the operating room.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
1. Kinford CW et al. End-to-Side Ileocolonic Anastomosis after Ileocecectomy for Crohn's Disease is a Safe Option with Low Recurrence. Dis Colon Rectum. 2026 Jun 17. doi: 10.1097/DCR.0000000000004346. PMID: 42302313.
2. Gurland B, et al. Stapled End-To-Side Ileocolic Anastomosis in Crohn's Disease: Old Dog, Reliable Tricks? A Retrospective Two-Center Cohort Study. J Gastrointest Surg. 2024.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A University of Chicago study finds that end-to-side ileocolonic anastomosis is a safe, technically easy option for Crohn's disease surgery. This configuration is associated with lower blood loss, shorter operative times, and significantly reduced recurrence rates compared to other configurations.
2 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
